[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE200300348A - Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist ning selle kasutamine - Google Patents

Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist ning selle kasutamine

Info

Publication number
EE200300348A
EE200300348A EEP200300348A EEP200300348A EE200300348A EE 200300348 A EE200300348 A EE 200300348A EE P200300348 A EEP200300348 A EE P200300348A EE P200300348 A EEP200300348 A EE P200300348A EE 200300348 A EE200300348 A EE 200300348A
Authority
EE
Estonia
Prior art keywords
solid
composition consisting
thrombin
fibrinogen
collagen carrier
Prior art date
Application number
EEP200300348A
Other languages
English (en)
Inventor
Stimmeder Dagmar
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of EE200300348A publication Critical patent/EE200300348A/et
Publication of EE05678B1 publication Critical patent/EE05678B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/36Surgical swabs, e.g. for absorbency or packing body cavities during surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/041Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/044Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/046Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00Macromolecular products derived from proteins
    • C08H1/06Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00365Plasters use
    • A61F2013/00463Plasters use haemostatic
    • A61F2013/00472Plasters use haemostatic with chemical means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Medicinal Preparation (AREA)
EEP200300348A 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine EE05678B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100135 2001-01-25
DKPA200100235 2001-02-13
PCT/IB2002/001453 WO2002058749A2 (en) 2001-01-25 2002-01-25 Carrier with solid fibrinogen and solid thrombin

Publications (2)

Publication Number Publication Date
EE200300348A true EE200300348A (et) 2003-10-15
EE05678B1 EE05678B1 (et) 2013-10-15

Family

ID=26068956

Family Applications (3)

Application Number Title Priority Date Filing Date
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga
EEP200300348A EE05678B1 (et) 2001-01-25 2002-01-25 Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist, ning selle kasutamine
EEP200300349A EE05587B1 (et) 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EEP200300341A EE05685B1 (et) 2001-01-25 2002-01-25 Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200300349A EE05587B1 (et) 2001-01-25 2002-01-25 Meetod kollageenk„sna valmistamiseks

Country Status (37)

Country Link
EP (4) EP1343542B1 (et)
JP (4) JP4535678B2 (et)
KR (2) KR100830294B1 (et)
CN (3) CN1264578C (et)
AR (3) AR032800A1 (et)
AT (2) ATE291445T1 (et)
AU (3) AU2002255220B2 (et)
BG (3) BG66343B1 (et)
BR (3) BRPI0206709B8 (et)
CA (3) CA2434964C (et)
CL (1) CL2015003111A1 (et)
CR (1) CR7034A (et)
CZ (3) CZ20032199A3 (et)
DE (2) DE60207389T2 (et)
DK (2) DK1368419T3 (et)
EA (4) EA005697B1 (et)
EE (3) EE05685B1 (et)
EG (2) EG26417A (et)
ES (2) ES2238569T3 (et)
HK (2) HK1058371A1 (et)
HR (1) HRP20030648B1 (et)
HU (3) HU228810B1 (et)
IL (6) IL157097A0 (et)
IS (1) IS6885A (et)
ME (1) ME00587B (et)
MX (3) MXPA03006689A (et)
NO (3) NO332462B1 (et)
NZ (3) NZ527166A (et)
PL (3) PL205181B1 (et)
PT (1) PT1343542E (et)
RS (1) RS50866B (et)
SI (2) SI1343542T1 (et)
SK (3) SK10342003A3 (et)
TW (2) TWI237573B (et)
UA (1) UA73028C2 (et)
UY (1) UY27136A1 (et)
WO (3) WO2002058750A2 (et)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131933A1 (en) * 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US20040131771A1 (en) * 2002-11-04 2004-07-08 Poul Egon Bertelsen Coating of particulate material with organic based coating composition for the preparation of drug delivery systems
CA2513319C (en) * 2003-01-20 2013-03-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic material comprising thrombin, fibrinogen and bioabsorbable synthetic nonwoven fabric
JP2006523113A (ja) 2003-04-04 2006-10-12 ティシュームド リミテッド 組織接着構成物
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
US7186684B2 (en) * 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US8133504B2 (en) 2004-08-03 2012-03-13 Tissuemed Limited Tissue-adhesive materials
PL2345430T3 (pl) 2004-10-20 2016-05-31 Ethicon Inc Wzmocniony, absorbowalny, wielowarstwowy materiał do zastosowania w wyrobach medycznych oraz sposób jego wytwarzania
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
ES2552233T3 (es) 2004-10-20 2015-11-26 Ethicon, Inc. Hemostato absorbible
KR20060040329A (ko) * 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
EP1879606B1 (en) 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
KR20080102152A (ko) 2006-02-03 2008-11-24 티슈메드 리미티드 조직-접착 물질
WO2007092998A1 (en) 2006-02-14 2007-08-23 Commonwealth Scientific And Industrial Research Organisation Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins
DK2012842T3 (en) 2006-04-25 2018-05-28 Massachusetts Inst Technology COMPOSITIONS AND PROCEDURES TO INFLUENCE THE MOVEMENT OF CONTAMINANTS, BODIES, OR OTHER UNITS AND / OR TO INFLUENCE OTHER PHYSIOLOGICAL CONDITIONS
ES2575933T3 (es) 2006-05-31 2016-07-04 Baxter International Inc. Colágeno para su uso en la prevención de la formación de fibrosis epidural después de cirugía espinal
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
WO2008019127A2 (en) * 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Solid dressing for treating wounded tissue
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
CN101053679B (zh) * 2007-04-17 2010-05-26 浙江大学 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法
DE102007037053A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum für die minimal-invasive Operation
DE102007037056A1 (de) 2007-07-24 2009-01-29 Aesculap Ag Hämostyptikum
DE102007045066A1 (de) 2007-09-20 2009-04-02 Mike Ehrlich Material zur Blutstillung enthaltend synthetische Peptide oder Polysaccharide
DE102007000574A1 (de) 2007-10-25 2009-04-30 FILK Forschungsinstitut für Leder- und Kunstbahnen gGmbH Biologisch resorbierbares Schwammmaterial und Verfahren zu dessen Herstellung
WO2009056298A2 (en) 2007-10-30 2009-05-07 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
CN101214391B (zh) * 2007-12-27 2010-05-19 广州倍绣生物技术有限公司 一种高效生物胶封闭剂及其应用
JP5569398B2 (ja) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー/エス 止血および/または創傷治癒を促進するための装置
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
CN102170919A (zh) 2008-10-06 2011-08-31 三维肽胶株式会社 组织闭塞剂
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
BRPI1015979A8 (pt) 2009-06-16 2018-06-19 Baxter Healthcare Sa esponja porosa hemostática, e, método para fabricar uma esponja porosa hemostática
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
JP2013514093A (ja) 2009-12-16 2013-04-25 バクスター・インターナショナル・インコーポレイテッド 止血スポンジ
KR101786786B1 (ko) * 2010-01-28 2017-10-18 옴릭스 바이오파머슈티컬스 리미티드 개선된 피브린 밀봉 방법
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
EP2575776B1 (en) 2010-06-01 2018-05-30 Baxter International Inc Process for making dry and stable hemostatic compositions
ES2629349T3 (es) 2010-06-01 2017-08-08 Baxter International Inc Procedimiento para obtener composiciones hemostáticas secas y estables
KR101967085B1 (ko) 2010-06-01 2019-04-08 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
CN103096944A (zh) * 2010-07-20 2013-05-08 一般财团法人化学及血清疗法研究所 组织粘合用片制剂
EP3243489B8 (en) * 2011-05-24 2022-03-23 Topaz Investment AS Rolled collagen carrier
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
CN102357259A (zh) 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
US20130041406A1 (en) * 2011-08-10 2013-02-14 Brian W. Bear Surgical staple with localized adjunct coating
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
KR102135484B1 (ko) 2011-10-11 2020-07-20 백스터 인터내셔널 인코포레이티드 지혈 조성물
ES2938568T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
PL2771027T3 (pl) 2011-10-27 2016-01-29 Baxter Int Kompozycje hemostatyczne
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2669569C2 (ru) 2012-05-14 2018-10-12 Тейдзин Лимитед Формованный пластинчатый продукт и гемостатический материал
CN104470475B (zh) 2012-05-24 2017-04-19 武田有限公司 用于提供卷绕的胶原蛋白载体的设备和工艺
CA2868396C (en) * 2012-05-24 2020-06-16 Takeda Nycomed As Packaging containing a form-stable coiled hemostatic collagen carrier
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
JP6389170B2 (ja) 2012-07-06 2018-09-12 スリーディー マトリックス, エルティーディー3−D Matrix, Ltd. ペプチド溶液のためのフィル−フィニッシュ過程
DE102013004420A1 (de) 2012-08-20 2014-02-20 Alexander Kopp Stützkörper und Verfahren zu seiner Herstellung
AU2013353931B2 (en) * 2012-12-07 2016-12-08 Baxter Healthcare S.A. Hemostatic foam
KR101401944B1 (ko) * 2012-12-11 2014-05-30 세원셀론텍(주) 콜라겐과 피브린이 혼합된 조직 실란트 및 그 제조방법
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー/エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
US10765774B2 (en) * 2013-07-09 2020-09-08 Ethicon, Inc. Hemostatic pad assembly kit and method
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ/エス 押し出し増強因子を含んでいる乾燥組成物
ES2711728T3 (es) 2014-03-10 2019-05-07 3 D Matrix Ltd Composiciones de péptidos de autoensamblaje
EP3116524B1 (en) 2014-03-10 2018-11-28 3-D Matrix Ltd. Autoassembling peptides for the treatment of pulmonary bulla
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
CN106730031A (zh) * 2016-12-30 2017-05-31 清华大学 一种用于脊髓损伤修复的仿生纤维蛋白水凝胶束及其制备方法
US11324703B2 (en) 2017-12-15 2022-05-10 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses thereof in drug delivery
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
RU2679616C1 (ru) * 2018-07-02 2019-02-12 Государственное бюджетное учреждение здравоохранения города Москвы Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ приготовления тромбофибринового сгустка, обладающего ростстимулирующими свойствами
KR102632571B1 (ko) * 2018-12-14 2024-01-31 가부시끼가이샤 비엠지 2반응제형의 시트형 조직 접착 보강재
CN112225937B (zh) * 2020-10-14 2022-11-01 中山大学 一种温敏型大孔生物水凝胶及其制备方法和应用
CN113117158B (zh) * 2021-03-10 2022-07-26 复旦大学 表面变性蛋白生物功能化修饰的材料及其制备方法和应用
CN114177346B (zh) * 2021-12-24 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种止血组合物及止血贴与其应用
CN114246974B (zh) * 2021-12-24 2023-11-03 中国人民解放军军事科学院军事医学研究院 一种止血贴的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1596789A (et) * 1968-11-27 1970-06-22
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
BR8102435A (pt) * 1981-04-15 1982-11-30 Campos Vidal Benedicto Colageno i microfibrilar e microcristalino para aplicacao em medicina e farmacia
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
US4626286A (en) * 1983-10-31 1986-12-02 Schmid Laboratories, Inc. Collagen gel and the process of making said gel
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
FR2668936B1 (fr) * 1990-11-09 1993-01-15 Eberlin Jean Luc Greffon a base de collagene et de colle de fibrine pour la reconstruction osteo-cartilagineuse et son procede de preparation.
DE69232374T2 (de) * 1991-04-08 2002-08-29 Koken Co. Ltd., Tokyo Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält
US6177126B1 (en) * 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
JPH0759812A (ja) * 1993-08-27 1995-03-07 Koken Co Ltd 創傷カバ−材及びその製造方法
CN1159206A (zh) * 1994-09-02 1997-09-10 纽约血库公司 由酵母生产和分泌重组血纤维蛋白原
CA2245585A1 (en) * 1996-02-06 1997-08-14 David P. Kosow Composition for sealing wounds
CA2251475C (en) * 1996-04-04 2006-09-05 Immuno Aktiengesellschaft Hemostatic sponge based on collagen
AU3873499A (en) * 1998-05-01 1999-11-23 Zymogenetics Inc. Fully recombinant tissue sealant compositions
JP4480270B2 (ja) * 1998-05-19 2010-06-16 ジ・アメリカン・ナショナル・レッド・クロス 止血サンドウィッチ包帯
WO2000009018A1 (en) * 1998-08-10 2000-02-24 Fibrogen, Inc. Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
EP1140235B2 (de) * 1998-12-23 2007-12-19 ZLB Behring GmbH Fibrinklebergranulat und verfahren zu dessen herstellung
DE19922078A1 (de) * 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie

Also Published As

Publication number Publication date
BG108123A (bg) 2004-09-30
ME00587A (en) 2011-12-20
EA200300821A1 (ru) 2004-04-29
EP1368419A2 (en) 2003-12-10
DE60207389D1 (de) 2005-12-22
CN1487843A (zh) 2004-04-07
HRP20030648B1 (en) 2011-10-31
HK1058371A1 (en) 2004-05-14
NO332462B1 (no) 2012-09-24
NZ527165A (en) 2005-02-25
TWI237573B (en) 2005-08-11
SK288120B6 (sk) 2013-09-03
DE60203364D1 (de) 2005-04-28
BG66439B1 (bg) 2014-08-29
SK10352003A3 (sk) 2004-02-03
EE05685B1 (et) 2013-12-16
KR20030086254A (ko) 2003-11-07
CZ20032198A3 (cs) 2003-12-17
EA006540B1 (ru) 2006-02-24
CZ304357B6 (cs) 2014-03-26
HUP0400768A3 (en) 2006-01-30
WO2002070594A8 (en) 2004-03-11
TWI255726B (en) 2006-06-01
BR0206709A (pt) 2004-02-17
BR0206708A (pt) 2004-02-25
EP1547626A3 (en) 2009-07-29
CZ20032199A3 (cs) 2003-12-17
IL157097A0 (en) 2004-02-08
PL206194B1 (pl) 2010-07-30
EG24589A (en) 2009-12-01
EE05587B1 (et) 2012-10-15
CL2015003111A1 (es) 2016-07-08
NO20033296D0 (no) 2003-07-22
NO20033296L (no) 2003-09-25
EE200300341A (et) 2003-10-15
BR0206705A (pt) 2004-02-25
BRPI0206705B8 (pt) 2021-07-27
ATE310044T1 (de) 2005-12-15
ES2253523T3 (es) 2006-06-01
HUP0303896A2 (hu) 2004-03-01
YU67003A (sh) 2006-05-25
MXPA03006688A (es) 2004-03-12
CN1290907C (zh) 2006-12-20
JP2004520124A (ja) 2004-07-08
UA73028C2 (uk) 2005-05-16
JP4535678B2 (ja) 2010-09-01
SK10362003A3 (sk) 2004-03-02
NO20033297L (no) 2003-09-25
WO2002058749A3 (en) 2002-10-10
HUP0303893A3 (en) 2012-02-28
UY27136A1 (es) 2002-09-30
IL157096A0 (en) 2004-02-08
SK10342003A3 (sk) 2004-02-03
CA2434964C (en) 2009-04-21
BRPI0206708B8 (pt) 2021-06-22
HUP0400768A2 (hu) 2004-07-28
DK1343542T3 (da) 2005-07-25
HK1058319A1 (en) 2004-05-14
BG108121A (bg) 2004-08-31
EE05678B1 (et) 2013-10-15
CZ305120B6 (cs) 2015-05-13
EE200300349A (et) 2003-10-15
WO2002058749A2 (en) 2002-08-01
ME00587B (me) 2011-12-20
MXPA03006687A (es) 2004-03-12
HUP0303896A3 (en) 2005-12-28
CA2435159C (en) 2009-07-28
HU227987B1 (hu) 2012-07-30
JP2005502733A (ja) 2005-01-27
EA200300822A1 (ru) 2004-02-26
KR100847417B1 (ko) 2008-07-18
WO2002070594A3 (en) 2003-01-03
CN1264578C (zh) 2006-07-19
PL205181B1 (pl) 2010-03-31
HRP20030648A2 (en) 2005-06-30
EA200401463A1 (ru) 2005-08-25
WO2002058750A8 (en) 2004-03-11
JP2004521115A (ja) 2004-07-15
ES2238569T3 (es) 2005-09-01
SI1343542T1 (en) 2005-10-31
ATE291445T1 (de) 2005-04-15
PT1343542E (pt) 2005-08-31
BG66343B1 (bg) 2013-07-31
BRPI0206708B1 (pt) 2015-07-14
KR20030085522A (ko) 2003-11-05
CN1246047C (zh) 2006-03-22
NO20033295D0 (no) 2003-07-22
KR100830294B1 (ko) 2008-05-16
NO20033295L (no) 2003-09-25
EA006686B1 (ru) 2006-02-24
EA200300823A1 (ru) 2004-04-29
EP1547626A2 (en) 2005-06-29
CR7034A (es) 2004-03-05
DE60203364T2 (de) 2005-09-01
EA005697B1 (ru) 2005-04-28
BRPI0206709B1 (pt) 2015-09-08
EP1343542A2 (en) 2003-09-17
JP4104462B2 (ja) 2008-06-18
PL366932A1 (en) 2005-02-07
EP1359947A2 (en) 2003-11-12
MXPA03006689A (es) 2004-03-12
NZ527166A (en) 2005-03-24
JP2007190399A (ja) 2007-08-02
IL157097A (en) 2009-12-24
AR032400A1 (es) 2003-11-05
AU2002307809B2 (en) 2007-10-04
HU228810B1 (hu) 2013-05-28
EP1368419B1 (en) 2005-11-16
PL363274A1 (en) 2004-11-15
CA2435425A1 (en) 2002-08-01
NO327386B1 (no) 2009-06-22
EP1343542B1 (en) 2005-03-23
WO2002058750A2 (en) 2002-08-01
NZ527167A (en) 2005-02-25
BG66420B1 (bg) 2014-03-31
EA006700B1 (ru) 2006-02-24
AR032800A1 (es) 2003-11-26
IL157095A0 (en) 2004-02-08
HUP0303893A2 (hu) 2004-03-01
IL157096A (en) 2007-08-19
SK287874B6 (sk) 2012-02-03
DK1368419T3 (da) 2006-04-03
IS6885A (is) 2003-07-24
RS50866B (sr) 2010-08-31
AU2002249528B2 (en) 2007-03-29
CZ20032197A3 (cs) 2003-11-12
BRPI0206709B8 (pt) 2021-06-22
AR032517A1 (es) 2003-11-12
IL157095A (en) 2009-06-15
PL363275A1 (en) 2004-11-15
WO2002070594A2 (en) 2002-09-12
PL206197B1 (pl) 2010-07-30
SI1368419T1 (sl) 2006-06-30
CA2434964A1 (en) 2002-08-01
CA2435159A1 (en) 2002-09-12
NO20033297D0 (no) 2003-07-22
DE60207389T2 (de) 2006-08-03
CA2435425C (en) 2010-07-27
WO2002058750A3 (en) 2002-10-31
BR0206705B1 (pt) 2012-08-07
AU2002255220B2 (en) 2007-05-31
BG108122A (bg) 2004-09-30
WO2002058749A8 (en) 2004-03-11
CN1487967A (zh) 2004-04-07
EG26417A (en) 2013-10-22
CN1507358A (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
EE200300348A (et) Tahke koostis, mis koosneb peamiselt kollageenkandjast, tahkest fibrinogeenist ja tahkest trombiinist ning selle kasutamine
DE60212544D1 (de) Modifiziertes Propylenpolymer, davon erhältliche Klebstoffzusammensetzung und Klebstoff, der dieses umfasst
BR0215405A (pt) Composições e processos de uso de collajolie
FR2848115B1 (fr) Composition de bacteries et son utilisation
ATE297907T1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase- aktivatoren
AU2002366083A1 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
NO20005265L (no) Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser
EP1587424A4 (en) Bleeding Compounds and their uses
DE69932222D1 (de) Zementzusatzstoff, Zementzusammensetzung und polymere Polycarbonsäure
AU2003239614A8 (en) Cardiolipin compositions, methods of preparation and use
EE05113B1 (et) Adhesiivssteem, k?vendi kompositsioon, nende kasutamine ja nende pealekandmismeetodid
DE60211106D1 (de) Zusammensetzung zur Oxidationsfärbung von Keratinfasern
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
DE60200374D1 (de) Endoparasitizide Gelzusammensetzung
EP1468087A4 (en) COMPOSITIONS, METHODS, AND KITS RELATING TO THROMBIN DECOMPOSITION RESISTANT FIBROBLAST GROWTH FACTOR 1
EE200000099A (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
AR028068A1 (es) Nuevos derivados de 1,1-dioxotiocromano y su uso como inhibidores de trombina
EE200200167A (et) Sünteetiline nahk, meetod selle valmistamiseks ning kasutamine
DE60115467D1 (de) Herstellungsverfahren und eigenschaften von styrol-butadien random-copolymer/poly(arylenether) zusammensetzungen
EE200300044A (et) Vasoprotektiivse ja antioksüdantse toimega preparaat ning selle kasutamine
DE60109730D1 (de) Zementzusatzmittel und Zementzusammensetzung
BR0315701B1 (pt) composiÇço, composiÇço de tratamento na lavagem de roupas, e, uso de uma composiÇço.
EE200100329A (et) Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod

Legal Events

Date Code Title Description
HC1A Change of owner name